TrialOncotarget2026

A randomized double-blind placebo-controlled phase I/II clinical trial of a human papillomavirus therapeutic vaccine, PepCan, for reducing head and neck squamous cell carcinoma recurrence.

Emily Bivens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.